000			01774 a2200397 4500
005			20250516223748.0
264		0	_c20150330
008			201503s 0 0 eng d
022			_a1435-702X
024	7		_a10.1007/s00417-014-2719-y _2doi
040			_aNLM _beng _cNLM
100	1		_aKlettner, Alexa
245	0	0	_aComparison of the efficacy of aflibercept, ranibizumab, and bevacizumab in an RPE/choroid organ culture. _h[electronic resource]
260			_bGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie _cOct 2014
300			_a1593-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal, Humanized _xpharmacology
650	0	4	_aBevacizumab
650	0	4	_aChoroid _xdrug effects
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aOrgan Culture Techniques
650	0	4	_aRanibizumab
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xpharmacology
650	0	4	_aRecombinant Fusion Proteins _xpharmacology
650	0	4	_aRetinal Pigment Epithelium _xdrug effects
650	0	4	_aSwine
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
700	1		_aRecber, Muhammed
700	1		_aRoider, Johann
773	0		_tGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie _gvol. 252 _gno. 10 _gp. 1593-8
856	4	0	_uhttps://doi.org/10.1007/s00417-014-2719-y _zAvailable from publisher's website
999			_c24029242 _d24029242